| Methods |
RCT. |
| Participants |
88 women. Cephalic, live fetus, ruptured membranes, Bishops score < 6, no evidence of infection. |
| Interventions |
IV oxytocin
vs
vaginal PGE2 tablets. |
| Outcomes |
C/S, cervix unfavourable after 24/48 hours, instrumental vaginal delivery, Apgar scores, maternal side effects, postpartum haemorrhage. |
| Notes |
No mention of randomisation or allocation technique. |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Adequate sequence generation? |
Unclear risk |
No information provided. |
| Allocation concealment? |
Unclear risk |
Not stated. |
| Blinding?
Women |
High risk |
Not feasible. Vaginal tablets were compared with IV oxytocin (no placebo). |
| Blinding?
clinical staff |
High risk |
|
| Blinding?
outcome assessor |
High risk |
|
| Free of selective reporting? |
Low risk |
|
